CSI Market
Sign In | Register

Fulgent Genetics Inc (FLGT) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access FLGT Annual Cash Flow →
Cash flow patterns shown here provide context for understanding Fulgent Genetics Inc's ability to sustain operations and capital deployment.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-109.35
Depreciation & amortization13.68
Amortization of Other Assets4.63
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Asset Impairment Charges2.17
Provision For Loan Losses Expensed4.86
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property-0.01
Share-based Compensation18.51
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Noncash Lease Expense-
Investment Income Amortization Of Premium-
Unrecognized Tax Benefits Operating Activities0.20
Increase Decrease In Contract With Customer Liability-0.63
Increase Decrease In Customer Deposit2.47
Investment Income Net Amortization Of Discount And Premium-0.89
Operating Lease Right Of Use Asset Amortization Expense0.35
Increase Decrease In Operating Lease Liability-0.38
Income taxes0.00
Marketable Securities, Realized Gain (Loss), Excluding Other than Temporary Impairments, Total0.09
Accounts Receivable-19.96
Increase (Decrease) in Accounts Payable-3.82
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities-14.02
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Taxes0.00
Other Working Capital-5.07
Other Noncash Income (Expense)0.05
Other net-0.64
Payments for (Proceeds from) Other Operating Activities92.22
Discontinued operations0.00
Net Cash flow from Operating Activities-16.66
Investing Activities
Capital Expenditures-9.06
Sale of Capital Items0.01
Proceeds from Sale and Maturity of Marketable Securities103.23
Payments to Acquire Marketable Securities-10.01
Real Estate Investments0.00
Proceeds From Maturity Of Marketable Securities-
Proceeds From Sale Of Marketable Securities-
Payments For Purchase Of Equipment Contributed To Equity Method Investee-
Payment For Purchase Of Redeemable Preferred Stock-
Payments To Acquire Equity Securities Fv Ni-
Payment For Contingent Consideration Liability Investing Activities-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired-55.57
Payments to Acquire Equity Method Investments0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net32.97
Discontinued operations0.00
Net Cash Flow from Investing Activities61.74
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-0.48
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-63.87
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net-4.53
Other net-0.18
Payments Of Cash Distributions-
Payments For Issuance Costs Of Preferred Units-
Tax Distribution To Class D Common And Preferred Unitholders-
Finance Lease Principal Payments-0.09
Repayment Of Notes Payable-
Repayment Of Investment Margin Loan-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents50.33
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-69.06
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-25.71
Total Cash Flow-23.89
4 historic quarters locked

Sign in to unlock the full Fulgent Genetics Inc cash flow history.

Sign In Create Free Account

About Fulgent Genetics Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-326136

Figures are derived from filed reports and may be restated. Historical data is subject to revision.